A review of the clinical efficacy of FDA-approved antibody‒drug conjugates in human cancers
Article in Molecular Cancer (March 2024)
The most recent citing publications are shown below. View all 2 publications that cite this research output on Dimensions.
Expression of HER2 in high-grade urothelial carcinoma based on Chinese expert consensus and the clinical effects of disitamab vedotin-tislelizumab combination therapy in the treatment of advanced patients
Article in Frontiers in Pharmacology (February 2024)